RSB Spine, LLC, Announces Additional FDA Clearance for the InterPlate® L-Ti
CLEVELAND, Sept. 13 /PRNewswire/ -- RSB Spine, LLC, today announced that the InterPlate® L-Ti has been cleared for an additional product code (KWQ). The L-Ti was previously cleared as an interbody fusion device.
RSB Spine Chief Executive Officer John A. Redmond said: "We are excited about this new clearance. Because of our Bridging Flush Fit™ design, we have always been of the opinion that the InterPlate L-Ti can function as an interbody fusion device and/or anterior lumbar plate. The new product code also simplifies coding for surgeons, clarifying reimbursement for this type of zero profile implant."
RSB Spine is a privately held medical device company focused on developing innovative spinal implants with a focus on modular fusion products. News releases and other information on the company are available on the Internet at: http://www.rsbspine.com.